Collection 專利 [0/6] 期刊論文 [31/31] 會議論文/會議摘要 [6/10] Siblings 于重元 [19/19] 劉柯俊 [87/107] 劉滄梧 [120/126] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [85/97] 常慧如 [40/45] 張俊彥 [234/254] 張光裕 [70/80] 張憶壽 [104/107] 張文祥 [52/54] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 李家惠 [29/29] 李岳倫 [49/55] 林素芳 [32/32] 楊奕馨 [44/45] 江士昇 [90/92] 沈哲宏 [14/16] 洪文俊 [88/92] 莊雙恩 [82/91] 蔡坤志 [32/35] 蔡慧珍 [67/85] 蘇勇曄 [41/41] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [46/49] 陳振陽 [72/72] 陳立宗 [447/518] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [39/40] 黃智興 [56/57] 黃道揚 [27/27] 丁兆治(2000-2004) [5/5] 其他 [470/478] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/56] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] Community Statistics 近3年內發表的文件:4(8.51%) 含全文筆數:37(78.72%) 文件下載次數統計 下載大於0次:37(100.00%) 下載大於100次:37(100.00%) 檔案下載總次數:28876(0.51%) 最後更新時間: 2025-02-26 17:24 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 単離抗体,医薬組成物,単離抗体結合体,ダイマー化阻害方法,シグナル伝達... 可標靶ＶＥＧＦＲ２與ＶＥＧＦＲ３的雙功能抗體 Dual-function antibodies targeting ... Dual-function antibodies targeting ... Downregulated salt-inducible kinase... ATP-binding cassette transporter, A... Low seroprevalence of Zika virus in... Salt-inducible kinase 3 expression ... Diagnosing the RGS11 lung cancer bi... BPR1J373, a novel multitargeted kin...

跳至: (選擇年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 47. (共2頁) 1 2 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2023-09-05	単離抗体,医薬組成物,単離抗体結合体,ダイマー化阻害方法,シグナル伝達阻害方法,管新生阻害方法,治療方法,および断片検出方法	JP7339325/2023-09-05
2023-09-01	可標靶ＶＥＧＦＲ２與ＶＥＧＦＲ３的雙功能抗體	TWI813649/2023-09-01
2023-04-11	Dual-function antibodies targeting VEGFR2 and VEGFR3	US11623960/2023-04-11
2023-03-30	Dual-function antibodies targeting VEGFR2 and VEGFR3	AU2019239984/2023-03-30
2019-10-23	Low seroprevalence of Zika virus infection among adults in Southern Taiwan	BMC Infectious Diseases. 2019 Oct 23;19:Article number 884.
2019-10-15	Downregulated salt-inducible kinase 3 expression promotes chemoresistance in serous ovarian cancer via the ATP-binding cassette protein ABCG2	Journal of Cancer. 2019;10(24):6025-6036.
2019-07	ATP-binding cassette transporter, ABCG2, activation is responsible for chemo-resistant, SIK3 low expressed ovarian cancer	Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 5146.
2019-03	Diagnosing the RGS11 lung cancer biomarker: The integration of competitive immunoassay and isothermal nucleic acid exponential amplification reaction	Analytical Chemistry. 2019 Mar;91(5):3327-3335.
2018-08-24	BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor	Cancer Science. 2018 Nov;109(11):3591-3601.
2018-07	Salt-inducible kinase 3 expression identifies long-term survivors of serous ovarian cancer	Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 639.
2018-02-08	Progress toward development of photodynamic vaccination against infectious/malignant diseases and photodynamic mosquitocides	Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2018 Feb 8;10479:Article number 1047912.
2017-11-16	In silico-based identification of human alpha-enolase inhibitors to block cancer cell growth metabolically	Drug Design Development and Therapy. 2017 Nov 16;11:3281-3290.
2016-10	BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT driven myeloid leukemia	Molecular Cancer Therapeutics. 2016 Oct;15(10):2323-2333.
2016-05	Overexpression of regulator of G protein signaling 11 promotes cell migration and associates with advanced stages and aggressiveness of lung adenocarcinoma	Oncotarget. 2016 May;7(21):31122-31136.
2015-09-26	Anti-alpha-enolase is a prognostic marker in postoperative lung cancer patients	Oncotarget. 2015 Sep 26;6(33):35073-35086.
2015-09	AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-kappaB activation	Leukemia and Lymphoma. 2015 Sep;56(9):2674-2682.
2015-05	Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells	Oncotarget. 2015 May;6(13):11098-11113.
2014-08	Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma	International Journal of Cancer. 2014 Aug;135(4):809–819.
2013-07-19	Surface alpha-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target	PLoS ONE. 2013 Jul 19;8(7):Article number e69354.
2013-06-20	Selecting tyrosine kinase inhibitors for gastrointestinal stromal tumor with secondary KIT activation-loop domain mutations	PLoS ONE. 2013 Jun 20;8(6):Article number e65762.
2013-03	Targeting to tumor-associated antigen eno1 provides preventive and therapeutic effects on disease progression of lung cancer	Annals of Oncology. 2013 Mar;24(Suppl. 1):27.
2013-02	Autophagy is involved in endogenous and NVP-AUY922-induced KIT degradation in gastrointestinal stromal tumors	Autophagy. 2013 Feb;9(2):220-233.
2012-09	Heat shock protein 90 inhibition downregulates c-Kit expression in gist cells through diminishing transcription and enhancing protein degradation via both autophagy and proteasome pathways	Annals of Oncology. 2012 Sep;23(Suppl. 9):538.
2012-03	Involvement of autophagy in endogenous and NVP-AUY922-induced C-kit degradation in both imatinib-sensitive and -resistant gastrointestinal stromal tumor cells	Annals of Oncology. 2012 Mar;23(Suppl. 1):28.
2011-10-21	Overexpression of alpha-enolase correlates with poor survival in canine mammary carcinoma	BMC Veterinary Research. 2011 Oct 21;7:Article Number 62.

顯示項目1-25 / 47. (共2頁) 1 2 > >> 每頁顯示[10|25|50]項目